GlassScriptPhysician profile
Lisa Morris
NPI 1730710344
$557.37
in general payments reported to CMS, 2019-2025
16 companies · $316 in 2025
The $316 reported for 2025 was more than what 76% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $119 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $116.96 | 2023-2025 | Slynd |
| Amgen INC. | $80.71 | 2023-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $51.97 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.03 | 2025 | Xifaxan |
| Hologic Sales and Service, LLC | $37.01 | 2023 | Aptima |
| Organogenesis INC. | $27.86 | 2025 | Puraply Wound Matrix |
| Lilly USA, LLC | $24.61 | 2025 | Zepbound |
| Exact Sciences Corporation | $23.42 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $20.40 | 2023 | |
| Glaxosmithkline, LLC. | $19.83 | 2025 | Bexsero |
| Boston Scientific Corporation | $19.19 | 2025 | Bulkamid |
| Phathom Pharmaceuticals, INC. | $19.19 | 2024 | Voquezna |
| Novo Nordisk INC | $19.06 | 2025 | Wegovy |
| Organon LLC | $18.63 | 2025 | Nexplanon |
| Astellas Pharma US INC | $17.26 | 2023 | Myrbetriq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $16.24 | 2025 | Flector, Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.